These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4728844)

  • 1. [Case of primary hyperlipemia treated with cynarin].
    Bobnis W; Szmatloch E; Wesolowska T; Wójcicki J; Zieliński T
    Wiad Lek; 1973 Jul; 26(13):1267-70. PubMed ID: 4728844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cynarin in the modern management of hyperlipemia].
    Pristautz H
    Wien Med Wochenschr; 1975 Dec; 125(49):705-9. PubMed ID: 820084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental and clinical studies on the hypolipemic action of 1,5-dicaffeoylquinic acid].
    Wójcicki J; Bobnis W; Olszewska M; Szmatloch E
    Pol Tyg Lek; 1974 Apr; 29(15):627-9. PubMed ID: 4828046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 1,5-dicafleylquinic acid (cynarine) on hypertriglyceridemia in aged patients].
    Mars G; Brambilla G
    Med Welt; 1974 Sep; 25(39):1572-4. PubMed ID: 4427557
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Cynarin on hyperlipidemia with special reference to type II (hypercholesterinemia)].
    Hammerl H; Kindler K; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Med Wochenschr; 1973 Oct; 123(41):601-5. PubMed ID: 4583824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cynarin and hyperlipidemia].
    Wójcicki J; Pieczyl-Mróz J; Ilnicka-Madry M; Cwajda H
    Wiad Lek; 1977 Oct; 30(19):1539-41. PubMed ID: 579267
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of cynarin on fatty liver].
    Eberhardt G
    Z Gastroenterol; 1973 Apr; 11(3):183-6. PubMed ID: 4803418
    [No Abstract]   [Full Text] [Related]  

  • 8. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 9. Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Trans Am Clin Climatol Assoc; 1968; 79():216-28. PubMed ID: 5760587
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia].
    Cagánová A; Cagán S
    Bratisl Lek Listy; 1972 Jul; 58(1):66-78. PubMed ID: 5077942
    [No Abstract]   [Full Text] [Related]  

  • 11. [New drug specialities, registered in Austria].
    Wien Klin Wochenschr; 1973 Nov; 85(48):798-9. PubMed ID: 4753091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
    Cloarec M
    Therapeutique; 1972 Dec; 48(10):653-6. PubMed ID: 4661289
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hyperlipoproteinemia in relation to recent classifications].
    Cloarec M
    Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of clofibrate on unsaturated fatty acids in lipid fractions of sera in patients with hyperlipemia].
    Felt V; Husek P
    Vnitr Lek; 1976 Mar; 22(3):256-61. PubMed ID: 1266086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical observations on the hypocholesteremic action of 1,5-dicaffeoyl ester of quinic acid].
    Cairella M; Volpari B
    Clin Ter; 1971 Jul; 57(6):541-52. PubMed ID: 5136488
    [No Abstract]   [Full Text] [Related]  

  • 17. Inefficiency of cynarin as therapeutic regimen in familial type II hyperlipoproteinaemia.
    Heckers H; Dittmar K; Schmahl FW; Huth K
    Atherosclerosis; 1977 Feb; 26(2):249-53. PubMed ID: 576409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations].
    Fabre J; Denizot M; Giromini M; Micheli H
    J Urol Nephrol (Paris); 1973; 79(4):381-3. PubMed ID: 4720134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of nephrotic syndromes with cynarine].
    Cieślińska K; Wójcicki J
    World Health Organ Tech Rep Ser; 1974 Mar; 27(5):457-62. PubMed ID: 4206989
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of nephrotic syndromes with cynarine].
    Cieślińska K; Wójcicki J
    Wiad Lek; 1974 Mar; 27(5):457-62. PubMed ID: 4850037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.